Neuromedin N vs Neuropeptide FF — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuromedin N (NMN) is a hexapeptide co-encoded in the same gene as neurotensin and processed from the same precursor protein. Its C-terminal sequence is structurally related to the active C-terminal fragment of neurotensin, sharing its Ile-Leu C-terminal dipeptide....
Calculate Neuromedin N dose →Neuropeptide FF (NPFF) is an endogenous octapeptide first isolated from bovine brain in 1985 and recognized as a key endogenous anti-opioid system component. NPFF is produced in the hypothalamus, brain stem, and spinal cord and acts on NPFF1 and NPFF2 receptors (GPCRs) to oppose ...
Calculate Neuropeptide FF dose →| Parameter | Neuromedin N | Neuropeptide FF |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Preclinical | Research |
| Half-Life | Very short (seconds-minutes) | Short (minutes) |
| Typical Dose | N/A (preclinical) | 0.1-10 nmol (central, animal) |
| Frequency | N/A | Variable |
| Route | ICV / IV (research) | Intrathecal, Intracerebroventricular (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.